Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancer.

IF 3.6 3区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Sophie M C Green, Christopher D Graham, Michelle Collinson, Pei Loo Ow, Louise H Hall, David P French, Nikki Rousseau, Hollie Wilkes, Christopher Taylor, Erin Raine, Rachel Ellison, Daniel Howdon, Robbie Foy, Rebecca E A Walwyn, Jane Clark, Catherine Parbutt, Jo Waller, Jacqueline Buxton, Sally J L Moore, Galina Velikova, Amanda J Farrin, Samuel G Smith
{"title":"Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancer.","authors":"Sophie M C Green, Christopher D Graham, Michelle Collinson, Pei Loo Ow, Louise H Hall, David P French, Nikki Rousseau, Hollie Wilkes, Christopher Taylor, Erin Raine, Rachel Ellison, Daniel Howdon, Robbie Foy, Rebecca E A Walwyn, Jane Clark, Catherine Parbutt, Jo Waller, Jacqueline Buxton, Sally J L Moore, Galina Velikova, Amanda J Farrin, Samuel G Smith","doi":"10.1093/tbm/ibae066","DOIUrl":null,"url":null,"abstract":"<p><p>Adherence to adjuvant endocrine therapy in women with breast cancer is low. We conducted a 24-1 fractional factorial pilot optimization trial to test four intervention components supporting medication adherence [text messages, information leaflet, acceptance and commitment therapy (ACT), self-management website], in the preparation phase of the multiphase optimization strategy. Guided by the National Institute of Health Behavior Change Consortium fidelity framework, we investigated fidelity of design, training, delivery, receipt, and enactment of four intervention components. Women prescribed adjuvant endocrine therapy (n = 52) were randomized to one of eight experimental conditions comprised of combinations of the four intervention components (ISRCTN: 10487576). We assessed fidelity using self-report data (4 months post-randomization), trial data, ACT session observations, behavior change technique (BCT) coding, and interviews with participants (n = 20) and therapists (n = 6). Design: Each intervention component targeted unique behavior change techniques with some overlap. Training: All 10 therapists passed the competency assessment. Delivery: All leaflets (27/27) and website (26/26) details were sent, and ACT procedural fidelity was high (85.1%-94.3%). A median of 32.5/41 (range 11-41) text messages were delivered, but a system error prevented some messages being sent to 22 of 28 participants. Receipt: Most participants [63.0% (ACT, leaflet) to 71.4% (text messages)] read all or at least some of the intervention components they were randomized to receive. Enactment was reported most positively for ACT. All intervention components demonstrated adequate fidelity. We have provided an exemplar for assessing fidelity using the National Institute of Health Behavior Change Consortium framework in the preparation phase of multiphase optimization strategy.</p>","PeriodicalId":48679,"journal":{"name":"Translational Behavioral Medicine","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Behavioral Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/tbm/ibae066","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Adherence to adjuvant endocrine therapy in women with breast cancer is low. We conducted a 24-1 fractional factorial pilot optimization trial to test four intervention components supporting medication adherence [text messages, information leaflet, acceptance and commitment therapy (ACT), self-management website], in the preparation phase of the multiphase optimization strategy. Guided by the National Institute of Health Behavior Change Consortium fidelity framework, we investigated fidelity of design, training, delivery, receipt, and enactment of four intervention components. Women prescribed adjuvant endocrine therapy (n = 52) were randomized to one of eight experimental conditions comprised of combinations of the four intervention components (ISRCTN: 10487576). We assessed fidelity using self-report data (4 months post-randomization), trial data, ACT session observations, behavior change technique (BCT) coding, and interviews with participants (n = 20) and therapists (n = 6). Design: Each intervention component targeted unique behavior change techniques with some overlap. Training: All 10 therapists passed the competency assessment. Delivery: All leaflets (27/27) and website (26/26) details were sent, and ACT procedural fidelity was high (85.1%-94.3%). A median of 32.5/41 (range 11-41) text messages were delivered, but a system error prevented some messages being sent to 22 of 28 participants. Receipt: Most participants [63.0% (ACT, leaflet) to 71.4% (text messages)] read all or at least some of the intervention components they were randomized to receive. Enactment was reported most positively for ACT. All intervention components demonstrated adequate fidelity. We have provided an exemplar for assessing fidelity using the National Institute of Health Behavior Change Consortium framework in the preparation phase of multiphase optimization strategy.

在试点优化试验中评估多维保真度:对支持乳腺癌妇女坚持用药的四项干预内容进行过程评估。
乳腺癌妇女辅助内分泌治疗的依从性很低。在多阶段优化策略的准备阶段,我们进行了一项 24-1 分数因子先导优化试验,以测试支持坚持用药的四个干预组成部分 [短信、信息传单、接受与承诺疗法 (ACT)、自我管理网站]。在美国国立卫生研究院行为改变联合会保真度框架的指导下,我们对四个干预措施的设计、培训、实施、接收和执行的保真度进行了调查。开具辅助内分泌治疗处方的妇女(n = 52)被随机分配到由四个干预成分组合而成的八个实验条件之一(ISRCTN:10487576)。我们使用自我报告数据(随机化后 4 个月)、试验数据、ACT 会话观察、行为改变技术 (BCT) 编码以及对参与者(n = 20)和治疗师(n = 6)的访谈来评估忠实性。设计:每个干预部分都针对独特的行为改变技术,但有一些重叠。培训:所有 10 名治疗师都通过了能力评估。实施:所有宣传单(27/27)和网站(26/26)的详细信息都已发送,ACT 程序的忠实度很高(85.1%-94.3%)。发送短信的中位数为 32.5/41(范围为 11-41),但由于系统错误,28 位参与者中有 22 位无法收到短信。接收情况:大多数参与者[63.0%(ACT、传单)至 71.4%(短信)]阅读了他们随机接受的全部或至少部分干预内容。对 "行动疗法 "的执行情况报告最为积极。所有干预内容都表现出足够的忠实性。在多阶段优化策略的准备阶段,我们提供了一个使用国家健康研究所行为改变联合会框架评估忠实性的范例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Translational Behavioral Medicine
Translational Behavioral Medicine PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH -
CiteScore
6.80
自引率
0.00%
发文量
87
期刊介绍: Translational Behavioral Medicine publishes content that engages, informs, and catalyzes dialogue about behavioral medicine among the research, practice, and policy communities. TBM began receiving an Impact Factor in 2015 and currently holds an Impact Factor of 2.989. TBM is one of two journals published by the Society of Behavioral Medicine. The Society of Behavioral Medicine is a multidisciplinary organization of clinicians, educators, and scientists dedicated to promoting the study of the interactions of behavior with biology and the environment, and then applying that knowledge to improve the health and well-being of individuals, families, communities, and populations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信